Understanding lung cancer differences among various racial and ethnic groups
Official title: Comprehensive molecular characterization of lung cancers in five racial/ethnic groups with disparate risk
Funded at University of Hawaii at Manoa · NIH-10755626 · Data updated 2026-11-12
This study looks at how lung cancer affects different racial and ethnic groups to find out why some people are more at risk than others, and it hopes to use this information to help create better prevention and treatment options for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project start | February 25, 2020 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $434,691 |
| NIH project number | 5R01MD014862-05 |
| Project ID | NIH-10755626 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from diverse racial and ethnic backgrounds who have been diagnosed with lung cancer.
✕Less likely to help
Patients who do not have lung cancer or those from racial/ethnic groups not included in the study may not benefit from this research.
What this research studies
This research investigates the molecular characteristics of lung cancers across five different racial and ethnic groups to understand why certain populations are at higher or lower risk for the disease. It examines factors such as smoking history, lifestyle, and biological responses to tobacco carcinogens. By analyzing tumor biology and gene expression profiles, the study aims to uncover the underlying mechanisms contributing to disparities in lung cancer risk and outcomes. Patients may benefit from insights that could lead to more personalized prevention and treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for lung cancer tailored to specific racial and ethnic groups.
How similar studies have gone: Previous studies have shown success in identifying racial and ethnic disparities in lung cancer risk, but this comprehensive molecular profiling approach is relatively novel.
Where this research is happening
-
University of Hawaii at Manoa
Honolulu, United States Active
Researchers
- Principal investigator: Park, Sungshim Lani — University of Hawaii at Manoa
- Study coordinator: Park, Sungshim Lani
Related research
Other NIH-funded projects on the same topics.
-
TRIM28 Inhibition for NOTCH2-Mutant Small Cell Lung Cancer
A new approach aims to exploit a weakness in a subset of small cell lung cancer by turning on immune-related signals when NOTCH2 is lost, potentially making tumors more visible to the immune system.
-
Genomic factors shaping lung cancer risk in Native Hawaiians and Pacific Islanders
This NIH grant focuses on understanding why Native Hawaiians, Pacific Islanders, and African Americans have higher lung cancer risk and poorer outcomes by studying tumor DNA and related molecular patterns.
-
PD-L1 PET tracer to guide immune therapy in non-small cell lung cancer
A Johns Hopkins team is testing a Gallium-68 PET tracer to better guide immune checkpoint therapy for people with non-small cell lung cancer.
-
Targeting SMARCA2 to treat lung cancers that lack SMARCA4
This work looks at whether blocking a protein called SMARCA2 can slow or stop lung cancers that have lost the related gene SMARCA4.
-
New medicines for lung cancers caused by KRAS or BRAF changes
Testing new medicines that block ERK/RAF signaling in people with lung cancer driven by KRAS or BRAF mutations.
-
Understanding lung cancer risks in Native Hawaiians
This research looks at the genetic differences in lung cancer among Native Hawaiians to better understand why they face higher risks and poorer outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.